StonvexLoading…
StonvexStonvexStonvexCore line items from UFCS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $369.44M | $1.39B | $1.02B | $666.59M |
Operating Income | $38.01M | $147.94M | $99.73M | $51.06M |
Net Income | $30.05M | $118.19M | $79.84M | $40.65M |
EPS (Diluted) | $1.15 | $4.48 | $3.03 | $1.54 |
Total Assets | $3.91B | $3.84B | $3.75B | $3.66B |
Total Liabilities | $2.96B | $2.90B | $2.86B | $2.82B |
Cash & Equivalents | $162.03M | $156.33M | $233.74M | $202.15M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 25.65M | 25.52M | 25.51M | 25.49M |